General Information of the Protein
Protein ID
PT02313
Protein Name
Rho-associated protein kinase 2
Secondarily
Protein Name
Rho-associated
coiled-coil-containing protein kinase 2
Rho-associated
coiled-coil-containing protein kinase II
RhoA-binding kinase 2
p150 ROK-alpha
p164 ROCK-2
Gene Name
ROCK2
Sequence
MSRPPPTGKMPGAPEAAAGDGAGAGRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDTEISKHAKNLICAFLTDREVRLGRNGVEEIKSASFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYFRENLLLSDSPPCRENDAIQTRKSEESQEIQKKLYALEEHLSSEVQAKEELEQKCKSINTRLEKTAKELEEEITFRKNVESTLRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQSSQISTEKVNQLQKQLDEANALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRISGLEEDLKTGKTLLAKVELEKRQLQEKLTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKTTKARLADKNKIYESIEEAKSEAMKEMEKKLLEERSLKQKVENLLLEAEKRCSILDCDLKQSQQKLNELLKQKDVLNEDVRNLTLKIEQETQKRCLMQNDLKMQTQQVNTLKMSEKQIKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEENEEKTKLCKELQQKKQDLQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDTQEQLSKLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGSDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGMDSSSIGSGPGDAEPDDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEPEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECSRCHIKCHKDHMDKKEEIIAPCKVYYDISSAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS
    Show/Hide
Organism
Rattus norvegicus, Rat
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
AGC protein kinase group
>
AGC protein kinase DMPK family
>
AGC protein kinase ROCK subfamily
Function
Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays a role in placental homeostasis during the perinatal period. Plays an important role in generating the circadian rhythm of the aortic myofilament Ca(2+) sensitivity and vascular contractility by modulating the myosin light chain phosphorylation.
    Show/Hide
Uniprot ID
Q62868
Ensembl ID
ENSG00000134318
Subcellular Location
Cytoplasm
Cell membrane
Nucleus
Cytoplasm
Cytoskeleton
Microtubule organizing center
Centrosome
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000238 , A7r5
Compound ID Compound Name Compound Formula
CP0673944
(S)-6-methoxy-N-(2-((S)-1-methylpyrrolidin-3-yloxy)-4-(1H-pyrazol-4-yl)phenyl)chroman-3-carboxamide
   Show/Hide
C25H28N4O4
 1
1
IC50 < 4 nM
   TI
   LI
   LO
   TS
CP0677050
(S)-N-(4-(1H-pyrazol-4-yl)-2-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-6-methoxychroman-3-carboxamide
   Show/Hide
C26H30N4O4
 1
1
IC50 < 4 nM
   TI
   LI
   LO
   TS
CP0721498
(S)-6-methoxy-N-(2-((R)-1-methylpyrrolidin-3-yloxy)-4-(1H-pyrazol-4-yl)phenyl)chroman-3-carboxamide
   Show/Hide
C25H28N4O4
 1
1
IC50 < 4 nM
   TI
   LI
   LO
   TS
CP0721518
(S)-N-(2-(2-(dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)-6-methoxychroman-3-carboxamide
   Show/Hide
C24H28N4O4
 1
1
IC50 < 4 nM
   TI
   LI
   LO
   TS
CP0755321
(S)-N-(2-(3-hydroxypropoxy)-4-(1H-pyrazol-4-yl)phenyl)-6-methoxychroman-3-carboxamide
   Show/Hide
C23H25N3O5
 1
1
IC50 < 4 nM
   TI
   LI
   LO
   TS
CP0716120
(R)-6-methoxy-N-(2-((R)-1-methylpyrrolidin-3-yloxy)-4-(1H-pyrazol-4-yl)phenyl)chroman-3-carboxamide
   Show/Hide
C25H28N4O4
 1
1
IC50 = 32 nM
   TI
   LI
   LO
   TS
CP0774025
(R)-N-(2-(2-(dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)-6-methoxychroman-3-carboxamide
   Show/Hide
C24H28N4O4
 1
1
IC50 = 43 nM
   TI
   LI
   LO
   TS
CP0717768
(R)-N-(4-(1H-pyrazol-4-yl)-2-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-6-methoxychroman-3-carboxamide
   Show/Hide
C26H30N4O4
 1
1
IC50 = 411 nM
   TI
   LI
   LO
   TS
CP0721499
(R)-N-(2-(3-hydroxypropoxy)-4-(1H-pyrazol-4-yl)phenyl)-6-methoxychroman-3-carboxamide
   Show/Hide
C23H25N3O5
 1
1
IC50 = 519 nM
   TI
   LI
   LO
   TS
CP0673945
(R)-6-methoxy-N-(2-((S)-1-methylpyrrolidin-3-yloxy)-4-(1H-pyrazol-4-yl)phenyl)chroman-3-carboxamide
   Show/Hide
C25H28N4O4
 1
1
IC50 = 900 nM
   TI
   LI
   LO
   TS